Clinical Trials on Elderly AML Patients in Germany

Total 23676 results

Pascoe Pharmazeutische Praeparate GmbH

Completed

PASCONAL NERVENTROPFEN in the Treatment of Nervous Diseases (174)

Sleep Disorders | Nervousness

Germany
University Hospital, Essen

Recruiting

Adaptive Radiotherapy in Patients With Gynecological Tumors (ProART)

Cervical Carcinoma | Radiation | Adaptive Radiotherapy | Image Guided Radiotherapy | Gynecological Tumor | Optimization | Curative Treatment | Adaptive Radiation Therapy

Germany
University Hospital, Essen

Recruiting

Prospective Validation of Adaptive Radiotherapy (ART) in Patients With Head and Neck Tumors (ART in HNT)

Head and Neck Cancer | Optimized Treatment | Radiation | Adaptive Radiotherapy | Protection of Organs at Risk | Dysphagia Reduction

Germany
Taiho Oncology, Inc.

Completed

A Study of TAS-120 in Patients With Advanced Solid Tumors

Breast Cancer | Gastric Cancer | Cholangiocarcinoma | Urothelial Cancer | Primary CNS Tumors | Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors

France, United States, Korea, Republic of, United Kingdom, Japan, Hong Kong, Australia, Taiwan, Italy, Canada, Germany, Netherlands, Spain
University Hospital Tuebingen

Completed

Stargardt Disease in Childhood

Stargardt Disease

Germany
Sanofi

Completed

Non-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 ml SYDNEY Auto-injector (MARS)

Atherosclerotic Cardiovascular Disease | Primary Hypercholesterolaemia and Mixed Dyslipidaemia

Germany
Martin-Luther-Universität Halle-Wittenberg

Unknown

Phase I/II Trial of ATRA and TCP in Patients With Relapsed or Refractory AML and no Intensive Treatment is Possible (TCP-AML)

AML

Germany
Moberg Pharma AB

Completed

Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head

Actinic Keratosis

Germany
Novartis Vaccines

Completed

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly Subjects

Seasonal Influenza

Germany
Sanofi

Completed

A Study to Observe How Insulin Glargine 300 U/ml is Working and is Tolerated in Elderly Patients ≥75 Years of Age With Type 2 Diabetes (ELDERLY-T)

Type 2 Diabetes Mellitus (T2DM)

Germany
Goethe University

Completed

Imatinib + MTC in Relapsed / Refractory Acute Myeloid Leukemia (AML)

AML

Germany
Amgen

Terminated

Safety Study of AMG 228 to Treat Solid Tumors

Melanoma | Cancer | Colorectal Cancer | Advanced Solid Tumors | Squamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung Cancer | Oncology | Tumors | Advanced Malignancy | Oncology Patients | Transitional Cell Carinoma of Bladder

Belgium, France, United States, Germany, Australia
iOMEDICO AG

Recruiting

Ivosidenib (TIBSOVO®) Combined With Azacitidine According to Current SmPC (CONFIDHENCE)

Acute Myeloid Leukemia (AML)

Germany
University of Bonn
Pfizer; RWTH Aachen University; Ludwig-Maximilians - University of Munich; Heidelberg... and other collaborators

Unknown

Phase II Study Testing the Tolerability and the Efficacy of Bosutinib in Chronic Phase CML Patients (BODO)

Chronic Myelogenous Leukaemia

Germany
Gesellschaft fur Medizinische Innovation - Hamatologie...

Recruiting

National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup

Newly-diagnosed APL (de Novo or Therapy-related) | Relapsed APL

Germany
Hannover Medical School
University Hospital, Ghent; Johann Wolfgang Goethe University Hospital; University... and other collaborators

Unknown

Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T

De Novo Akute Myeloid Leukemia (AML) | Secondary Acute Myeloid Leukemia (AML) | Refractory Anemia With Excess of Blasts in Transformation

Germany
German CML Study Group

Unknown

Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Leukemia

Germany
Universität Duisburg-Essen
University Hospital, Essen; Helios Hospital Krefeld; Oslo Centre for Biostatistics...

Recruiting

Cardiorespiratory Fitness in Children and Adolescents After Cancer Treatment. (POWER)

All Types of Pediatric Cancer

Germany
University Hospital Carl Gustav Carus

Completed

Prophylactic Transfer of Leukemia-reactive T Cells After Allogeneic Transplantation

Chronic Myeloid Leukemia

Germany
University of Jena

Active, not recruiting

Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose (Ponderosa)

Chronic Myeloid Leukemia, Chronic Phase

Germany
Otsuka Pharmaceutical Development & Commercialization...

Completed

Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Agitation in Patients With Dementia of the Alzheimer's Type

United States, Estonia, Germany, Poland, Portugal, Puerto Rico
Boehringer Ingelheim

Recruiting

A Study in Healthy Men to Test How Different Doses of BI 3031185 Are Tolerated and How Food Influences the Amount of BI 3031185 in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121 is Taken as a Tablet or a Drink.

Healthy

Germany
Boehringer Ingelheim

Terminated

A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body With or Without Food

Healthy

Germany
LEO Pharma

Completed

A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men and Women to Test Which Effects Memantine and BI 425809 Have on Each Other

Healthy

Germany
Boehringer Ingelheim

Completed

This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Looks at How Food Influences the Amount of BI 1358894 in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

Study to Investigate the Relative Bioavailability, Influence of Pantoprazole Coadministration and Food Effect of Different Oral Formulation of BI 113608

Healthy

Germany
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers, Including Investigation of the Effect of Food on the Bioavailability of BI 1181181

Healthy

Germany
Boehringer Ingelheim

Completed

Investigation of the Effect of Food on the Bioavailability of a 25 mg Empagliflozin Tablet as Well as Assessment of Dose Proportionality Between 10 mg and 25 mg Empagliflozin Tablets Under Fasting Conditions.

Healthy

Germany
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Early Pharmacodynamics of Single Rising Oral Doses of BI 1021958 Tablets in Healthy Male Volunteers

Healthy

Germany
Janssen-Cilag International NV

Completed

Effects of Canagliflozin on C-peptide Clearance in Healthy Volunteers

Healthy

Germany
Sanofi
Bristol-Myers Squibb

Completed

Pharmacodynamic and Pharmacokinetic Study of 2 Different Dose Regimen of Clopidogrel in CYP2C19 Genotyped Healthy Subjects

Healthy

Germany
Oystershell NV
Bioskin GmbH

Completed

Assessment of Wound Healing, Cooling Efficacy and Local Tolerability of a Wound Care Hydrogel

Wound

Germany
Aker Biomarine Antarctic AS
BioTeSys GmbH

Completed

Uptake of an Omega-3 Oil in Healthy Adults

Pharmacokinetics | Absorption

Germany
University Medical Center Goettingen

Completed

Elaboration and Feedback for Clinical Reasoning Training

Medical Education

Germany
Bayer

Completed

A Study to Learn More About the Safety of Ultravist in Children and in the Elderly

Hypersensitivity

Germany
BHR Pharma, LLC

Terminated

Study of Progesterone in Treatment of Vasomotor Symptoms (PROGEST)

Menopause Related Conditions

Germany
Pascoe Pharmazeutische Praeparate GmbH
Daacro

Completed

Pilot Study on the Efficacy of Pascoflair in an Acute Stressful Situation (TSST)

Healthy | Stress

Germany
Heinrich-Heine University, Duesseldorf

Completed

Investigation on the Sustained Effect of Anthocyanins on Endothelial Function in Postmenopausal Women (Anthocyanins)

Post-menopausal Women

Germany
UCB Pharma
Otsuka Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects

Healthy Volunteers

Germany
Orexa BV
QPS Holdings LLC

Recruiting

Preventing Gastrointestinal Disturbance in Patients After Longitudinal Laparotomy. (ORE001PIIPOI)

Ileus Postoperative

Germany
Technische Universität Dresden
ISMG, Medical Faculty, Otto-von-Guericke University Magdeburg; Scientific Institute...

Recruiting

Evaluation of a Flexible and Integrative Psychiatric Care Model at the Pfalzklinikum (EVA_Pfalz) (EVA_Pfalz)

Mental Health Care

Germany
Neuropsychiatrischen Zentrums Hamburg-Altona
University of Hamburg-Eppendorf

Recruiting

Internet-delivered Psycho-oncological Support (ICBT_MAC)

Cancer

Germany
German CLL Study Group
Gilead Sciences; Hoffmann-La Roche

Completed

Sequential Regimen of Bendamustine-Debulking Followed by CAL-101 and GA101-Induction and -Maintenance in CLL (CLL2-BCG)

Chronic Lymphocytic Leucemia

Germany
University Hospital, Essen

Completed

Transfer of Cardioprotection During RIPC

CABG

Germany
Carl Zeiss Meditec AG

Completed

Visual Outcomes After Presbyopic Lens Exchange (RELAX)

Presbyopia

Germany
German CLL Study Group
Hoffmann-La Roche; Janssen-Cilag Ltd.

Completed

Sequential Regimen of Bendamustin [B] Followed by GA101 and Ibrutinib [I] in CLL Patients

Chronic Lymphocytic Leucemia

Germany

3

Subscribe